A small molecule CXCR4 antagonist inhibits neointima formation and smooth muscle progenitor cell mobilization after arterial injury.
Karshovska
E
E
Zagorac
D
D
Zernecke
A
A
Weber
C
C
Schober
A
A
D000818:Animals; D001158:Arteries / Q000293:injuries*; D002465:Cell Movement / Q000187:drug effects*; D023903:Coronary Restenosis / Q000517:prevention & control; D051379:Mice; D009131:Muscle, Smooth, Vascular / Q000166:cytology; D011725:Pyridines / Q000494:pharmacology*; D019718:Receptors, CXCR4 / Q000037:antagonists & inhibitors*; D013234:Stem Cells / Q000502:physiology; D015607:Stents / Q000009:adverse effects; D017539:Tunica Intima / Q000187:drug effects* / Q000254:growth & development
C503590:N-(1,4,8,11- tetraazacyclotetradecanyl-1,4-phenylenebis(methylene))-2-(aminomethyl)- pyridine; D011725:Pyridines; D019718:Receptors, CXCR4